Jamaica vs United Arab Emirates: Drug use disorder deaths by sex
Jamaica
1.35 deaths
in 2021
United Arab Emirates
1.1 deaths
in 2021
Jamaica rank
127th
United Arab Emirates rank
129th
Drug use disorder deaths by sex over time
- Jamaica
- United Arab Emirates
How they compare
Jamaica currently reports 1.35 deaths against 1.1 deaths in United Arab Emirates, a difference of 0.25 deaths.
That makes Jamaica's figure about 1.2 times United Arab Emirates's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Jamaica ahead.
Jamaica ranks 127th and United Arab Emirates ranks 129th of 194 countries.
Across the 3 decades both report, Jamaica averaged higher in 2 and United Arab Emirates in 1.
Head to head by decade
| Decade | Jamaica | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.964 deaths | 0.736 deaths | 0.228 deaths | Jamaica |
| 2010s | 1.02 deaths | 1.34 deaths | 0.32 deaths | United Arab Emirates |
| 2020s | 1.29 deaths | 1.05 deaths | 0.245 deaths | Jamaica |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher drug use disorder deaths by sex, Jamaica or United Arab Emirates?
- Jamaica, at 1.35 deaths against 1.1 deaths in United Arab Emirates as of 2021.
- What is the difference in drug use disorder deaths by sex between Jamaica and United Arab Emirates?
- 0.25 deaths, with Jamaica ahead.
- How many years of comparable data are there for Jamaica and United Arab Emirates?
- 22 years are reported by both, from 2000 to 2021.
- How do Jamaica and United Arab Emirates rank globally for drug use disorder deaths by sex?
- Jamaica ranks 127th and United Arab Emirates ranks 129th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Drug use disorder deaths by sex. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from drug use disorders in females.